TIP_link_300x300.jpg
Dermatology OTC Medications Market Worth $21.31Bn, Globally, by 2028 at 4.7% CAGR - Exclusive Report by The Insight Partners
25 mars 2022 06h46 HE | The Insight Partners
New York, March 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
22157.jpg
Global Acne Market Report 2021-2025 & 2030 with Focus on Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide
13 déc. 2021 06h33 HE | Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Acne Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. The global acne...
22157.jpg
Worldwide Radiation Dermatitis Industry to 2030 - Featuring 3M Company, Molnlycke Health Care and Intermed Among Others
07 avr. 2021 07h58 HE | Research and Markets
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Radiation Dermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been added to...
CreAgri's HIDROX(R) Receives International Patent for Psoriasis and Other Inflammatory Skin Conditions
08 juil. 2013 06h30 HE | CreAgri, Inc.
HAYWARD, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- A natural and innovative formulation of olive polyphenols for the management of inflammation based skin ailments, including Psoriasis, Eczema and...
U.S. Patent Office Allows Laurantis Application for Treatment of Skin Inflammation
01 août 2012 08h00 HE | Laurantis Pharma Oy
TURKU, FINLAND--(Marketwire - Aug 1, 2012) - The United States Patent and Trademark Office has allowed a patent application by Laurantis Pharma Oy (Laurantis) as it pertains to the topical...